Macquarie Group LTD Edwards Lifesciences Corp Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Macquarie Group LTD holds 152,757 shares of EW stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

152,757

Previous 1,831,316 91.66%

Holding current value

$11.3 Million

Previous $169 Million 94.04%

% of portfolio

0.01%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $100 Million - $157 Million	-1,678,559 Reduced 91.66%	152,757 $10.1 Million
Q2 2024 Aug 09, 2024	SELL	$84.3 - $94.31 $2.95 Million - $3.3 Million	-35,043 Reduced 1.88%	1,831,316 $169 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $9.71 Million - $12.8 Million	-133,921 Reduced 6.7%	1,866,359 $178 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $2.12 Million - $2.68 Million	-34,431 Reduced 1.69%	2,000,280 $153 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $22.7 Million - $30.6 Million	328,211 Added 19.23%	2,034,711 $141 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $1.58 Million - $1.83 Million	19,440 Added 1.15%	1,706,500 $161 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $44.9 Million - $51.1 Million	-605,178 Reduced 26.4%	1,687,060 $140 Million
Q4 2022 Feb 21, 2023	BUY	$68.3 - $87.44 $14.2 Million - $18.2 Million	208,090 Added 9.98%	2,292,238 $171 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $53.9 Million - $70.2 Million	653,969 Added 45.73%	2,084,148 $172 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $11.8 Million - $17.5 Million	-136,134 Reduced 8.69%	1,430,179 $136 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $10.9 Million - $13.7 Million	-106,921 Reduced 6.39%	1,566,313 $184 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $3.99 Million - $4.9 Million	-37,524 Reduced 2.19%	1,673,234 $217 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $17.1 Million - $20.4 Million	-166,487 Reduced 8.87%	1,710,758 $194 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $21.6 Million - $27 Million	257,857 Added 15.92%	1,877,245 $194 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $8.25 Million - $9.51 Million	-104,912 Reduced 6.08%	1,619,388 $135 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $18.2 Million - $23.2 Million	254,030 Added 17.28%	1,724,300 $157 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $78.1 Million - $102 Million	1,162,530 Added 377.76%	1,470,270 $117 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $11.6 Million - $15.5 Million	201,835 Added 190.58%	307,740 $21.3 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $406,911 - $628,884	-7,764 Reduced 6.83%	105,905 $20 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $5.58 Million - $6.39 Million	77,855 Added 217.39%	113,669 $26.5 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $186,434 - $228,477	-3,029 Reduced 7.8%	35,814 $7.88 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $153,006 - $176,805	-2,745 Reduced 6.6%	38,843 $7.18 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $777,542 - $1.04 Million	-16,236 Reduced 28.08%	41,588 $7.96 Million
Q4 2018 Feb 15, 2019	SELL	$46.41 - $56.94 $226,016 - $277,297	-4,870 Reduced 7.77%	57,824 $8.86 Million
Q3 2018 Nov 15, 2018	BUY	$45.7 - $58.03 $436,435 - $554,186	9,550 Added 17.97%	62,694 $10.9 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $126,034 - $152,309	-2,969 Reduced 5.29%	53,144 $7.74 Million
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $515,081 - $657,182	-13,850 Reduced 19.8%	56,113 $7.83 Million
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $21,084 - $24,579	624 Added 0.9%	69,963 $7.77 Million
Q3 2017 Nov 08, 2017	BUY	$36.29 - $38.83 $2.52 Million - $2.69 Million	69,339	69,339 $7.58 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Edwards Lifesciences Corp Transaction History